Investment Rating - The investment rating for the company is "Buy" and is maintained [9]. Core Insights - The company reported a significant increase in performance for the third quarter, with a revenue of 4.83 billion yuan, representing a year-on-year increase of 6.70%. The net profit attributable to the parent company reached 0.45 billion yuan, a substantial increase of 255.54% year-on-year [2][6]. - The company is focusing on optimizing its asset structure and business layout, with increased investments in new businesses such as biogas. The biogas sector is expected to experience rapid industrialization driven by favorable policies, with a projected increase in production from 9.6 billion cubic meters in 2024 to 74.8 billion cubic meters by 2040, reflecting a compound annual growth rate of 14% [2][12]. - The company aims to achieve a biogas production capacity of 500,000 cubic meters per day by 2025 and 1 million cubic meters per day by 2027, indicating strong growth potential in this sector [12]. Financial Performance Summary - For the first three quarters of 2025, the company achieved a total revenue of 12.78 billion yuan, a decrease of 12.29% year-on-year. The net profit attributable to the parent company was 0.08 billion yuan, down 39.80% year-on-year. However, the adjusted net profit showed a reduction in losses, reaching -0.01 billion yuan [2][6]. - The company's operating costs decreased by 17.85% to 9.57 billion yuan, leading to an improvement in gross margin by 5.07 percentage points to 25.1% [12]. - The comprehensive expense ratio for the first three quarters was 26.45%, a decrease of 1.65 percentage points year-on-year, with sales expenses significantly reduced by 37.17% [12].
维尔利(300190):单三季度业绩显著增长,生物天然气未来可期